Metabolic syndrome and the risk of suicide: A community-based integrated screening samples cohort study

Psychosomatic Medicine

Volumn 75, Issue 9, 2013, Pages 807-814

  Chang, Jung Chen ^a,c   Yen, Amy Ming Fang ^e   Lee, Chau Shoun ^e,g   Chen, Sam Li Sheng ^d   Chiu, Sherry Yueh Hsia ^h   Fann, Jean Ching Yuan ^f   Chen, Hsiu Hsi ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f Kainan University ^*  (Taiwan)

^g KAINAN UNIVERSITY   (Taiwan)

^h CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

blood pressure; community based integrated screening samples; hypertension; metabolic syndrome; mood disorders; suicide

Indexed keywords

LIPID;

ADULT; ARTICLE; COHORT ANALYSIS; COMMUNITY SAMPLE; CONFIDENCE INTERVAL; DEMOGRAPHY; ELEVATED BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INDEPENDENT VARIABLE; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC SYNDROME X; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SUICIDE; SUICIDE ATTEMPT; TAIWAN;

BLOOD PRESSURE; COMMUNITY-BASED INTEGRATED SCREENING SAMPLES; HYPERTENSION; METABOLIC SYNDROME; MOOD DISORDERS; SUICIDE;

ADULT; COHORT STUDIES; DEMOGRAPHY; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MASS SCREENING; MENTAL DISORDERS; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SUICIDE; TAIWAN;

EID: 84888127431     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000014     Document Type: Article

References (67)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28
2. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG. Overweight, obesity, and depression: A systematic review and meta-Analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67:220-9
3. Hawton K, van Heeringen K. Suicide. Lancet 2009;373:1372-81
4. Jakovljevic M, Crncevic Z, Ljubicic D, Babic D, Topic R, Saric M. Mental disorders and metabolic syndrome: A fatamorgana or warning reality? Psychiatry Danub 2007;19:76-86
5. van Heeringen K. The neurobiology of suicide and suicidality. Can J Psychiatry 2003;48:292-300
6. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999;160:1-12
7. Sarchiapone M, Camardese G, Roy A, Della Casa S, Satta MA, Gonzalez B, Berman J, De Risio S. Cholesterol and serotonin indices in depressed and suicidal patients. J Affect Disord 2001;62:217-9
8. Coryell W, Schlesser M. Combined biological tests for suicide prediction. Psychiatry Res 2007;150:187-91
9. Marques AH, Silverman MN, Sternberg EM. Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Ann N Y Acad Sci 2009;1179:1-18
10. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: Findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005;7:424-30
11. Chang JC, Chen HH, Yen AM, Chen SL, Lee CS. Survival of bipolar depression, other type of depression and comorbid ailments: Ten-year longitudinal follow-up of 10,922 Taiwanese patients with depressive disorders (KCIS no. PSY1). J Psychiatr Res 2012;46:1442-8
12. Cheng AT. Mental illness and suicide. A case-control study in east Taiwan. Arch Gen Psychiatry 1995;52:594-603
13. Cheng AT, Mann AH, Chan KA. Personality disorder and suicide. A casecontrol study. Br J Psychiatry 1997;170:441-6
14. Baldessarini RJ, Tondo L. Suicide risk and treatments for patients with bipolar disorder. JAMA 2003;290:1517-9
15. Vuksan-Cusa B, Marcinko D, Nad S, Jakovljevic M. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:109-12
16. Chen TH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS, Tung TH, Huang CC, Chan CC, Shiu MN, Yeh YP, Liou HH, Liao CS, Lai HC, Chiang CP, Peng HL, Tseng CD, YenMS, HsuWC, Chen CH. Communitybased multiple screening model: Design, implementation, and analysis of 42,387 participants. Cancer 2004;100:1734-43
17. Wang PE, Wang TT, Chiu YH, Yen AM, Chen TH. Evolution of multiple disease screening in Keelung: A model for community involvement in health interventions? J Med Screen 2006;13(suppl 1): S54-8
18. Chiu YH, Chen LS, Chan CC, Liou DM, Wu SC, Kuo HS, Chang HJ, Chen TH. Health information system for community-based multiple screening in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 3). Int J Med Inform 2006;75:369-83
19. Chiu SY, Chen LS, Yen AM, Chen HH. Population-based proband-oriented pedigree information system: Application to hypertension with populationbased screening data (KCIS No. 25). J Am Med Inform Assoc 2012; 19:102-10
20. Chiu YH, Wu SC, Tseng CD, Yen MF, Chen TH. Progression of prehypertension, stage 1 and 2 hypertension (JNC 7): A population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9). J Hypertens 2006;24:821-8
21. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol In Adults. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
22. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Geneva, Switzerland: World Health Organization; 2000
23. Wu CS, Wang SC, Cheng YC, Gau SS. Association of cerebrovascular events with antidepressant use: A case-crossover study. Am J Psychiatry 2011;168:511-21
24. Lu TH, Tsau SM, Wu TC. The automated classification of medical Eentities (ACME) system objectively assessed the appropriateness of underlying cause-of-death certification and assignment. J Clin Epidemiol 2005;58:1277-81
25. Yen AM, Chen LS, Chiu YH, Boucher BJ, Chen TH. A prospective community-population-registry based cohort study of the association between betel-quid chewing and cardiovascular disease in men in Taiwan (KCIS no. 19). Am J Clin Nutr 2008;87:70-8
26. McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PE Jr, Leverich GS, Altshuler L, Denicoff KD, Nolen WA, Kupka R, Grunze H, Walden J, Post RM. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207-13
27. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150: 1115-21
28. Golomb BA, Mednick SA, Tenkanen L. Suicide: A weighty matter? Arch Intern Med 2007;167:1908
29. Virkkunen M, Goldman D, Nielsen DA, Linnoila M. Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiatry Neurosci 1995;20:271-5
30. Lester D. Serum cholesterol levels and suicide: A meta-Analysis. Suicide Life Threat Behav 2002;32:333-46
31. Tanskanen A, Vartiainen E, Tuomilehto J, Viinamaki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry 2000; 157:648-50
32. Brunner J, Bronisch T, Pfister H, Jacobi F, Hofler M, Wittchen HU. High cholesterol, triglycerides, and body-mass index in suicide attempters. Arch Suicide Res 2006;10:1-9
33. Pompili M, Innamorati M, Lester D, Girardi P, Tatarelli R. Nearly lethal resuscitated suicide attempters have no low serum levels of cholesterol and triglycerides. Psychol Rep 2010;106:785-90
34. Lee HJ, Kim YK. Serum lipid levels and suicide attempts. Acta Psychiatr Scand 2003;108:215-21
35. Chang SS,Wen CP, Tsai MK, Lawlor DA, Yang YC, Gunnell D. Adiposity, its related biologic risk factors, and suicide: A cohort study of 542,088 Taiwanese adults. Am J Epidemiol 2012;175:804-15
36. Krishnan V, Nestler EJ. Linking molecules to mood: New insight into the biology of depression. Am J Psychiatry 2010;167:1305-20
37. Moon M, Kim S, Hwang L, Park S. Ghrelin regulates hippocampal neurogenesis in adult mice. Endocr J 2009;56:525-31
38. Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. Clin Investig 2009;119:717-25
39. Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, Roth RH, SleemanMW, Picciotto MR, Tschop MH, Gao XB, Horvath TL. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. Clin Investig 2006;116: 3229-39
40. Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN, Maratos-Flier E, Flier JS. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006;51:811-22
41. Silver MA. Depression and heart failure: An overview of what we know and don't know. Cleve Clin J Med 2010;77(suppl 3):S7-11
42. Terry PD, Abramson JL, Neaton JD. Blood pressure and risk of death from external causes among men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 2007;165:294-301
43. Giltay EJ, Zitman FG, Menotti A, Nissinen A, Jacobs DR Jr, Adachi H, Kafatos A, Kromhout D. Respiratory function and other biological risk factors for completed suicide: 40 years of follow-up of European cohorts of the Seven Countries Study. J Affect Disorder 2010;120:249-53
44. Jee SH, Kivimaki M, Kang HC, Park IS, Samet JM, Batty GD. Cardiovascular disease risk factors in relation to suicide mortality in Asia: Prospective cohort study of over one million Korean men and women. Eur Heart J 2011;32:2773-80
45. Golomb BA, Tenkanen L,Alikoski T, Niskanen T,Manninen V, HuttunenM, Mednick SA. Insulin sensitivity markers: Predictors of accidents and suicides in Helsinki Heart Study screenees. J Clin Epidemiol 2002;55:767-73
46. Newcomer JW. Metabolic syndrome and mental illness. Am J Manag Care 2007;13(suppl 7):S170-7
47. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006;3:A42
48. Newcomer JW. Medical risk in patients with bipolar disorder and schizophrenia. J Clin Psychiatry 2006;67(suppl 9):25-30; discussion 36-42
49. American Diabetes Association, APA Endocrinologists AAoC. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27:596-601
50. Carnethon MR, Kinder LS, Fair JM, Stafford RS, Fortmann SP. Symptoms of depression as a risk factor for incident diabetes: Findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992. Am J Epidemiol 2003;158:416-23
51. Arroyo C, Hu FB, Ryan LM, Kawachi I, Colditz GA, Speizer FE, Manson J. Depressive symptoms and risk of Type 2 diabetes in women. Diabetes Care 2004;27:129-33
52. Golden SH, Williams JE, Ford DE, Yeh HC, Paton Sanford C, Nieto FJ, Brancati FL. Depressive symptoms and the risk of Type 2 diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2004;27: 429-35
53. Carnethon MR, Biggs ML, Barzilay JI, Smith NL, Vaccarino V, Bertoni AG, Arnold A, Siscovick D. Longitudinal association between depressive symptoms and incident Type 2 diabetes mellitus in older adults: The cardiovascular health study. Arch Intern Med 2007;167:802-7
54. Everson-Rose SA, Meyer PM, Powell LH, Pandey D, Torrens JI, Kravitz HM, Bromberger JT, Matthews KA. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004; 27:2856-62
55. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007;62:31-8
56. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun 2009;23:936-44
57. Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry 2003;60:1009-14
58. Howren MB, Lamkin DM, Suls J. Associations of depression with Creactive protein, IL-1, and IL-6: A meta-Analysis. Psychosom Med 2009; 71:171-86
59. Vuksan-Cusa B, Jakovljevic M, Sagud M, Mihaljevic Peles A, Marcinko D, Topic R, Mihaljevic S, Sertic J. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA. Psychiatry Res 2011;189:21-5
60. Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Cur Diabetes Rev 2007;3:252-9
61. Champaneri S, Wand GS, Malhotra SS, Casagrande SS, Golden SH. Biological basis of depression in adults with diabetes. Cur Diabetes Rep 2010;10:396-405
62. Nihalani N, Schwartz TL, Siddiqui UA, Megna JL. Weight gain, obesity, and psychotropic prescribing. J Obesity 2011;2011:article ID 893629
63. Gracious BL, Meyer AE. Psychotropic-induced weight gain and potential pharmacologic treatment strategies. Psychiatry (Edgmont) 2005;2:36-42
64. Reaven GM. The metabolic syndrome: Time to get off the merry-go-round? J Intern Med 2011;269:127-36
65. Reaven GM. The individual components of the metabolic syndrome: Is there a raison d'etre? J Am Coll Nutr 2007;26:191-5
66. Fang F, Fall K, Mittleman MA, Sparen P, YeW, Adami HO, Valdimarsdottir U. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med 2012;366:1310-8
67. Yu GP, Mehta V, Branovan D, Huang Q, Schantz SP. Non-cancer-related deaths from suicide, cardiovascular disease, and pneumonia in patients with oral cavity and oropharyngeal squamous carcinoma. Arch Otolaryngol Head Neck Surg 2012;138:25-32